Literature DB >> 30075881

Variability in the Management Recommendations Given for High-risk Breast Lesions Detected on Image-guided Core Needle Biopsy at U.S. Academic Institutions.

Eniola Falomo1, Catherine Adejumo2, Kathryn A Carson3, Susan Harvey4, Lisa Mullen4, Kelly Myers4.   

Abstract

The purpose of this study was to describe and compare the management recommendations provided in the setting of a high-risk lesion diagnosed on core needle biopsy of the breast at academic institutions across the United States. We contacted breast imagers at U.S. academic institutions via email and asked them to complete a voluntary online survey. The survey consisted of eight questions regarding the management recommendations given when core biopsy yields various high-risk lesions. We received survey responses from 41 of the 59 institutions contacted (69% response rate). Surgical excision was the most frequently reported recommendation given for all high-risk lesions; however, the proportion varied from 95% for atypical ductal hyperplasia and papilloma with associated atypia, 76% for flat epithelial atypia, 73% for radial scar/complex sclerosing lesion, 71% for lobular carcinoma in-situ, 61% for atypical lobular hyperplasia, to 39% for intraductal papilloma without atypia. Our study demonstrates inconsistency in the management recommendations given for high-risk lesions detected on core needle biopsy at academic institutions nationally. This outcome suggests that patients may benefit from the creation of consensus recommendations for the management of high-risk lesions detected on core needle biopsy.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30075881     DOI: 10.1067/j.cpradiol.2018.06.004

Source DB:  PubMed          Journal:  Curr Probl Diagn Radiol        ISSN: 0363-0188


  7 in total

1.  High-risk lesions in the breast diagnosed by MRI-guided core biopsy: upgrade rates and features associated with malignancy.

Authors:  Eumee Cha; Emily B Ambinder; Eniola T Oluyemi; Lisa A Mullen; Babita Panigrahi; Joanna Rossi; Philip A Di Carlo; Kelly S Myers
Journal:  Breast Cancer Res Treat       Date:  2022-10-15       Impact factor: 4.624

Review 2.  Artificial Intelligence: A Primer for Breast Imaging Radiologists.

Authors:  Manisha Bahl
Journal:  J Breast Imaging       Date:  2020-06-19

Review 3.  Papillary neoplasms of the breast including upgrade rates and management of intraductal papilloma without atypia diagnosed at core needle biopsy.

Authors:  Edi Brogi; Melissa Krystel-Whittemore
Journal:  Mod Pathol       Date:  2020-10-26       Impact factor: 7.842

4.  Performance of a clinical and imaging-based multivariate model as decision support tool to help save unnecessary surgeries for high-risk breast lesions.

Authors:  Dogan S Polat; Jennifer G Schopp; Firouzeh Arjmandi; Jessica Porembka; Venetia Sarode; Deborah Farr; Yin Xi; Basak E Dogan
Journal:  Breast Cancer Res Treat       Date:  2020-10-03       Impact factor: 4.872

5.  Trends in frequency and outcome of high-risk breast lesions at core needle biopsy in women recalled at biennial screening mammography, a multiinstitutional study.

Authors:  Jacky D Luiten; Bram Korte; Adri C Voogd; Willem Vreuls; Ernest J T Luiten; Luc J Strobbe; Matthieu J C M Rutten; Menno L Plaisier; Paul N Lohle; Marianne J H Hooijen; Vivianne C G Tjan-Heijnen; Lucien E M Duijm
Journal:  Int J Cancer       Date:  2019-05-02       Impact factor: 7.396

Review 6.  Are Columnar Cell Lesions the Earliest Non-Obligate Precursor in the Low-Grade Breast Neoplasia Pathway?

Authors:  Sarah Strickland; Gulisa Turashvili
Journal:  Curr Oncol       Date:  2022-08-11       Impact factor: 3.109

7.  The value of imaging combined with clinicopathological features in the diagnosis of high-risk breast lesions.

Authors:  Jiayin Zhou; Shiyun Sun; Luyi Lin; Tingting Jiang; Xiaoxin Hu; Yajia Gu; Chao You
Journal:  Gland Surg       Date:  2022-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.